Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1Phase 3 1

Status

Active not recruiting 3Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2NETWORK 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Dermatologic 6CNS 1

Conditions

Colorectal Neoplasms 8Melanoma 6Colonic Neoplasms 4Rectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Lung Neoplasms 2Thyroid Neoplasms 1Solid Tumors 1Skin Neoplasms 1Pancreatic Neoplasms 1Neurofibromatosis 1 1Neoplasms 1Lymphatic Metastasis 1Leukemia, Hairy Cell 1Hereditary Sensory and Autonomic Neuropathies 1Gastrointestinal Neoplasms 1Disease Progression 1Digestive System Neoplasms 1Brain Neoplasms 1Biliary Tract Neoplasms 1

Interventions

pembrolizumab 57Nivolumab 50Ipilimumab 31Specimen Handling 23Magnetic Resonance Spectroscopy 19Cyclophosphamide 14Biopsy 11fludarabine 10binimetinib 10Opdualag 10trametinib 9relatlimab 9Radiosurgery 9CTLA-4 Antigen 9dabrafenib 8lifileucel 7fludarabine phosphate 7aldesleukin 7encorafenib 6Interleukin-2 6cemiplimab 5atezolizumab 5Paclitaxel 5Blood Specimen Collection 5X-Rays 4Taxes 4Pemetrexed 4Gemcitabine 4Cisplatin 4Carboplatin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Melanoma × encorafenib × 90 days × Clear all
NCT04074096 2026-06-05

BEPCOME-MB

UNICANCER

Phase 2 Active not recruiting
10 enrolled
CNSDermatologic

Brain Neoplasms, Melanoma

NCT04221438 2026-05-29

Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement

Eastern Cooperative Oncology Group

Phase 2 Terminated
3 enrolled 11 charts
Dermatologic

Lymphatic Metastasis, Melanoma

NCT07092410 2026-04-21

SuRage-EB

SRH Wald-Klinikum Gera GmbH

Phase 4 Withdrawn
Dermatologic

Melanoma

NCT05026983 2026-04-16

Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases

M.D. Anderson Cancer Center

Phase 2 Recruiting
35 enrolled
Dermatologic

Melanoma

NCT07022457 2026-04-13

UK-EnBiRiM

Pierre Fabre Ltd

Active not recruiting
50 enrolled
Dermatologic

Melanoma

NCT04657991 2026-04-07

A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma

Pfizer

Phase 3 Active not recruiting
257 enrolled
Dermatologic

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡